Labcorp to Announce Fourth Quarter Financial Results on February 6, 2025
Labcorp to Announce Fourth Quarter Financial Results on February 6, 2025
BURLINGTON, N.C., Jan. 8, 2025 /PRNewswire/ -- Labcorp Holdings Inc. (NYSE: LH), a global leader of innovative and comprehensive laboratory services, will release its financial results for the fourth quarter of 2024 before the market opens on Thursday, February 6, 2025. The company will host a conference call and webcast beginning at 9 a.m. ET that day to discuss the results. The earnings press release and accompanying financial information will be posted on the Labcorp Investor Relations website.
北卡羅來納州伯靈頓,2025年1月8日 /PRNewswire/ -- Labcorp Holdings Inc. (紐交所: LH),作爲全球創新和綜合實驗室服務的領導者,將於2025年2月6日星期四市場開盤前公佈2024年第四季度的財務業績。該公司將在當天上午9點(東部時間)舉辦電話會議和網絡直播,討論財務結果。業績新聞稿及相關財務信息將發佈在Labcorp投資者關係網站上。
The call will be webcast live on the Labcorp Investor Relations website. Participants may also register for the call by clicking on this link, to receive the dial-in numbers and unique PIN to access the call. The webcast and dial-in are listen-only. It is recommended that participants join 10 minutes prior to the start, although participants may register and join at any time during the call.
此次電話會議將通過Labcorp投資者關係網站進行實時網絡直播。參與者也可以通過點擊此鏈接註冊電話會議,以獲取撥入號碼和獨特的PIN碼以參與會議。網絡直播和撥入僅供收聽。建議參與者在開始前10分鐘加入,儘管參與者可以在電話會議期間的任何時間註冊並加入。
A replay of the webcast will be available approximately two hours after the conclusion of the live event and will be available until January 24, 2026. To access the webcast recording, visit the Labcorp Investor Relations website.
網絡直播的回放將在現場活動結束後約兩個小時內提供,並將持續至2026年1月24日。要訪問網絡直播錄音,請訪問Labcorp投資者關係網站。
About Labcorp
Labcorp (NYSE: LH) is a global leader of innovative and comprehensive laboratory services that helps doctors, hospitals, pharmaceutical companies, researchers and patients make clear and confident decisions. We provide insights and advance science to improve health and improve lives through our unparalleled diagnostics and drug development laboratory capabilities. The company's more than 67,000 employees serve clients in approximately 100 countries, provided support for 84% of the new drugs and therapeutic products approved in 2023 by the FDA, and performed more than 600 million tests for patients around the world. Learn more about us at .
關於Labcorp
Labcorp(紐交所:LH)是創新和綜合實驗室服務的全球領導者,幫助醫生、醫院、藥品公司、研究人員和患者做出明確且自信的決策。我們提供見解,推動科學,以通過我們無與倫比的診斷和藥物研發實驗室能力改善健康和生活。該公司擁有超過67,000名員工,爲約100個國家的客戶提供服務,支持了FDA在2023年批准的84%新藥和治療產品,併爲全球患者進行了超過60000萬次測試。了解更多關於我們的信息。
SOURCE Labcorp
來源:Labcorp
WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?
想讓貴公司的資訊在PRNEWSWIRE.COM上特色展示嗎?
譯文內容由第三人軟體翻譯。